Rpg Life Sciences Limited · NSE:RPGLIFE
Rpg Life Sciences — RPG Annual Investor Conference 2022
13 slides from Rpg Life Sciences's conference presentation, Sep 13, 2022
Slide 1: Exchange cover letter: Investor Presentation
RPG LIFE SCIENCES LIMITED Unit No. 208-213, B Wing, Bezzola Complex, Sion-Trombay Road, Chembur, Mumbai 400071, India Tel: +91-22-25292152-55 Fax: +91 -22-25297423 RPO LIFE SCIENCES September 13, 2022 To The Manager BSE Limited Listing Department Corporate Relationship Department National Stock Exch
Slide 2: RPG Annual Investor Conference
hello happiness L RPG LIFE SCIENCES RPG Annual Investor Conference RPG Life Sciences September 14, 2022 ~» R?Ci I £
Slide 3: Disclaimer
Disclaimer This presentation may include statements which may constitute forward-looking statements. All statements that address expectations or projections about the future, including, but not limited to, statements about the strategy for growth, business development, market position, expenditures,
Slide 4: RPG Life Sciences Overview
RPG Life Sciences Overview Product breakup Leader in Immunosuppressants Domestic Formulations (DF) APIs Branded formulations in India & Nepal i) 6 Leading Text Book Brands 16% International Formulations (IF) International Formulations Domestic Formulations Generics and branded generics in Regulated
Slide 5: Key Financial Trends
Key Financial Trends (All figures in Rs. Crores except EPS in Rs.) Revenue from Operations f EBITDA & EBITDA Margin f PBT & PBT Margin f 440.2 89.4 73.2 375.6 389.1 70.8 1111 . □ ~ 330.2 59.9 53.6 41.8 34.4 29.1 25.1 128.9 15.1 □ 10.4% 15.9% 18.2% 20.3% 22.5% 4.6% 11.1% 13.8% 16.6% 19.5% FY19 FY20 F
Slide 6: Key Financial Trends
Key Financial Trends ROCE% f ROE% f Debt/Equity Ratio ! 27.9% 0.22 23.6% 24.3% 18.5% 20.1% 16.4% 11.0% -- 6.7% 0.06 ■ 0.01 0.00 FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 FY19 FY20 FY21 FY22 Company continues to remain Debt-free ~» R?Ci I £
Slide 7: Company Financial Performance Profit Margins
Company Financial Performance Profit Margins Consistent Trajectory EBITDA Margin reaches 22.5% & PBT Margin 19.5% EBITDA% 22.5% 20% PBT% 18% 19.5% 17% 16% 14% 12% 11% 10% 10% 10% 9% 8% 6% 6% 5% 4% 4% 4% 4% 1% 0% 0% All historic numbers are rounded-off to full integers ~» R?Ci I £
Slide 8: Key Financials: Q1 FY 2022-23
Key Financials: Q1 FY 2022-23 Revenue from Operations EBITDA & EBITDA Margin t t PBT & PBT Margin t 128.9 29.1 108.1 25.1 23.4 19.3 jJY 21.6% 22.5% 17.8% 19.5% FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 PAT & PAT Margin t EPS t 18.2 11.0 13.6 jY 8.2 12.6% 14.1% FY22 Q1 FY23 Q1 FY22 Q1 FY23 Q1 (
Slide 9: Key Highlights of Q1 FY 2022-23
Key Highlights of Q1 FY 2022-23 Well executed priorities in Domestic Formulations ►► Faster than market growth - 20.9%* vs 6.6%** 1. Augment product 3. Enhance productivity portfolio 4. Deepen customer 2. Build strategic brands/ coverage assets 5. Enhance margins 30% PBT growth; despite inflation, g
Slide 10: RPG Life Sciences ICRA Rating Reaffirmed in FY22
RPG Life Sciences ICRA Rating Reaffirmed in FY22 • Long term rating reaffirmed at A • Short term rating reaffirmed at A1 • Outlook on long term rating retained as Stable Rating reaffirmation factors: ► Strong brands in the Indian Pharmaceutical Industry ► Significant improvement in operating perform
Slide 11: ESG Targets and Initiatives
ESG Targets and Initiatives Environment Goals Social Goals Governance Goals Carbon Emission Diversity & Inclusion Data Integrity 33% reduction in FY23 Energy Consumption 15% reduction in FY23 , 50% increase in gender diversity in FY23 Product Responsibility Strict Quality Vigil Digitalization across
Slide 12: FY 2022-23 priorities
FY 2022-23 priorities Sustain growth momentum (top-line, Acquire new customers in IF and API bottom-line, all business segments) (Continue to) grow in chronic and specialty in DF (new product, new customer segments) -[E Accelerate digital transformation ~ ~J (Continue to) build iconic/legacy brands
Slide 13: hello happiness
.... hello happiness ~» R?Ci I £
RPG Life Sciences — RPG Annual Investor Conference 2022 on 6ix